MILLENDO THERAPEUTICS Competitors, Revenue and Alternatives
Estimated Revenue & Financials
- MILLENDO THERAPEUTICS's estimated annual revenue is currently $5.3M per year.
- MILLENDO THERAPEUTICS's estimated revenue per employee is $155,000
- MILLENDO THERAPEUTICS's total funding is $112M.
- MILLENDO THERAPEUTICS has 34 Employees.
- MILLENDO THERAPEUTICS grew their employee count by -23% last year.
- MILLENDO THERAPEUTICS currently has 1 job openings.
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Pricing|
|Thermo Fisher S...||$108.2M||698||17%||N/A||N/A|
What Is MILLENDO THERAPEUTICS?
Millendo Therapeutics is focused on developing novel treatments for endocrine diseases. Our mission is to build a leading endocrine company that creates distinct and transformative treatments for a wide range of diseases where there is a significant unmet medical need. We are currently advancing two product candidates: livoletide (AZP-531) and nevanimibe (ATR-101). Livoletide is being developed for Prader-Willi syndrome while nevanimibe is in development for the treatment of two different orphan adrenal diseases: Classic Congenital Adrenal Hyperplasia (CAH) and Endogenous Cushing's Syndrome (CS).keywords:Licensing,Biotechnology,Healthcare,Pharmaceuticals
Number of Employees
Employee Growth %
|Pharis Mohideen||Chief Medical Officer||Email Available|
|Renee Nivala||Director, Financial Reporting|
|Jiangyin Bao||Manager, Analytical Chemistry In Cmc|
|Thomas Hoover||Svp, Commercial Strategy|
|Vivian Lin||Senior Medical Director||Email Available|
|Lou Arcudi||CFO||Email Available|
|Habib Dable||Member Board Of Directors|
|Alicia Goodman||Head Of Hr||Email Available|
|Andrew Spencer||SVP Preclinical Research & Development||Email Available|
MILLENDO THERAPEUTICS News
Millendo Therapeutics, Inc. (MLND), a clinical-stage biopharmaceutical company primarily focused on developing novel treatments for orphan ...
Zynerba Pharmaceuticals (NASDAQ:ZYNE) and Millendo Therapeutics (NASDAQ:MLND) are both small-cap medical companies, but which is ...
ANN ARBOR, Mich.--(BUSINESS WIRE)--. Millendo Therapeutics, Inc. (MLND), a clinical-stage biopharmaceutical company developing novel ...
MILLENDO THERAPEUTICS Executive Hires
|2014-11-13||Pharis Mohideen||Chief Medical Officer||Article|
|2015-10-02||Jeffery M. Brinza||SVP Administration & General Counsel||Article|
|2016-04-15||Thomas Hoover||VP Commercial Strategy||Article|
|2016-10-14||John Kirk||VP Regulatory Affairs||Article|
|2016-11-18||Christopher Seiter||Chief Financial Officer||Article|
|2018-06-29||Ryan Zeidan||Senior Vice President, Development||Article|
MILLENDO THERAPEUTICS Acquisitions